{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-002522","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2023-04-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.712290+00:00","generated_at":"2026-06-16T23:29:52.451722+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Sunshine Biopharma amends bylaws to set quorum at one-third of outstanding shares","bullets":["Quorum for shareholder meetings now one-third of outstanding common voting stock.","Amendment adopted on April 17, 2023; no other bylaw changes disclosed.","Fiscal year unchanged; no impact on capital structure or business operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-002522","json":"https://secwatch.observer/filing/0001683168-23-002522.json","markdown":"https://secwatch.observer/filing/0001683168-23-002522.md","text":"https://secwatch.observer/filing/0001683168-23-002522.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/0001683168-23-002522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T23:29:52.451722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"877cb763ca865b255d647c3d896d4c2f3bb57797","claim":"Sunshine Biopharma Inc.: Amendment to bylaws changing the quorum requirement for common voting stock to one-third of outstanding shares (effective 2023-04-17).","evidence_excerpt":"On April 17, 2023, Sunshine Biopharma, Inc. (the “Company”) adopted an amendment to the Company’s bylaws. Pursuant to the amendment, one-third of the outstanding shares of the Company's common voting stock will constitute a quorum.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/0001683168-23-002522-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-04-17"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}